1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection.
Vila
J
J
Biron
F
F
Nugier
F
F
Vallet
T
T
Peyramond
D
D
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000998:Antiviral Agents; D016049:Didanosine; D006918:Hydroxyurea